Anti-HIV-1 protease triterpenoids from Stauntonia obovatifoliola Hayata subsp intermedia

被引：50
|
作者：
Wei, Ying [1 ]
Ma, Chao-Mei [1 ]
Chen, De-Yuan [2 ]
Hattori, Masao [1 ]
机构：
[1] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan
[2] Guiyang Coll Tradit Chinese Med, Dept Pharm, Guiyang 550002, Peoples R China
来源：
PHYTOCHEMISTRY | 2008年 / 69卷 / 09期
关键词：
Stauntonia obovatifoliola; Lardizabalaceae; triterpenoid; 16 beta-hydroxy-2,3-seco-lup-20(29)-ene-2,3-dioic acid; 3 beta,21 beta,24-trihydroxy-30-noroleana-12,20(29)-dien-28-oic acid and 16 beta-hydroxylupane-1,20(29)-dien-3-one; HIV-1 protease inhibitors;
D O I：
10.1016/j.phytochem.2008.03.004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Three triterpenoids, 16 beta-hydroxy-2,3-seco-lup-20(29)-ene-2,3-dioic acid (1), 3 beta,21 beta,24-trihydroxy-30-noroleana-12,20(29)-dien-28-oic acid (2) and 16 beta-hydroxylupane-1,20(29)-dien-3-one (3), along with eleven known triterpenes were isolated from stems of Stauntonia obovatifoliola Hayata subsp. intermedia (Y.C. Wu) T. Chen. Their structures were determined by analysis of HR-EI/FAB-MS and 1D and 2D NMR spectroscopic data and comparison with those in the literature. Ten of the compounds showed inhibitory activity against HIV-1 protease. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1875 / 1879
页数：5
相关论文
共 50 条
  • [41] Anti-HIV-1 protease activities of crude extracts of some Garcinia species growing in Tanzania
    Magadula, Joseph J.
    Tewtrakul, Supinya
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (12): : 1848 - 1852
  • [42] Potential anti-inflammation nor-oleanane triterpenoids from the fruits of Stauntonia brachyanthera
    Yang, Wei
    Chen, Mei
    Meng, Dali
    Wei, Peifeng
    NATURAL PRODUCT RESEARCH, 2019, 33 (23) : 3350 - 3356
  • [43] Importance of anti-HIV-1 antibodies - Reply
    Parren, PWHI
    Sattenau, QJ
    Burton, DR
    NATURE MEDICINE, 1997, 3 (06) : 591 - 591
  • [44] Anti-HIV-1 activity of inorganic polyphosphates
    Lorenz, B
    Leuck, J
    Kohl, D
    Muller, WEG
    Schroder, HC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (02): : 110 - 118
  • [45] ANTI-HIV-1 RIBOZYMES - PROSPECTS AND PROBLEMS
    ROSSI, JJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 862 - 862
  • [46] The anti-HIV-1 activity associated with saliva
    Shine, N
    Konopka, K
    Duzgunes, N
    JOURNAL OF DENTAL RESEARCH, 1997, 76 (02) : 634 - 640
  • [47] ANTI-HIV-1 ACTIVITY OF CURDLAN SULFATE
    AOKI, T
    KANEKO, Y
    TING, RCY
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 675 - 675
  • [48] Anti-HIV-1 drugs and endothelial dysfunction
    Agrawal, KC
    Pradhan, L
    Lu, K
    Ali, M
    Mondal, D
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) : 839 - 839
  • [49] Status of anti-HIV-1 chemotherapy in Japan
    Oishi, T
    Sugiura, W
    Matsuda, M
    Abumi, H
    Okano, A
    Yamada, K
    Koike, M
    Taki, M
    Ishikawa, M
    Miura, T
    Fukutake, K
    Gouchi, K
    Ajisawa, A
    Iwamoto, A
    Hanabusa, H
    Mimaya, J
    Takamatsu, J
    Takata, N
    Kakishita, E
    Higasa, S
    Yoshioka, A
    Kashiwagi, S
    Shirahata, A
    Nagai, Y
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 1999, 52 (02) : 51 - 52
  • [50] Developments of Indoles as Anti-HIV-1 Inhibitors
    Xu, Hui
    Lv, Min
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (18) : 2120 - 2148
12345